A clear company name behind the trading programme.
Future Peptides is a B2B sourcing and presentation programme operated through Hebei Meilan Biotechnology Co., Ltd. Brand identity and legal identity serve different purposes.
One company identity. Several public brands.
Future Peptides presents selected B2B sourcing routes. It is not a separate manufacturing company and this website makes no general GMP certification claim.
The legal seller named on commercial documents is Hebei Meilan Biotechnology Co., Ltd. / 河北美岚生物科技有限公司. Keep this entity consistent when you compare the website, quotation, contract, invoice and payment instruction.
- Business-to-business enquiries only.
- No dosing, treatment, personal-use or medical guidance.
- Product availability is subject to destination-market review.
- Certifications and manufacturing claims are confirmed for the exact product and batch.
Company details buyers can compare.
Use the same company name across the documents in your purchasing file.
- English company name
- Hebei Meilan Biotechnology Co., Ltd.
- Chinese company name
- 河北美岚生物科技有限公司
- Location
- Shijiazhuang, Hebei, China
- Public programme
- FUTURE PEPTIDES
- Business model
- B2B quotation, documentation and shipment planning
- Trade contact
- sales@hengyuepeptide.com
+852 4447 6465
How the programme stays commercially consistent.
The operating rules are deliberately narrow. Where a requirement falls outside them, the answer should be a written clarification or a decline.
One seller identity
Quotation, contract, invoice and beneficiary should align. A changed payment instruction must be verified independently.
No implied approval
Listing a material is not a statement that it is approved for every use, market or buyer type.
Written scope
Specifications, OEM work, testing, freight and documentation limits are confirmed in writing.